JP6269888B1 - 医薬用途 - Google Patents

医薬用途 Download PDF

Info

Publication number
JP6269888B1
JP6269888B1 JP2017132416A JP2017132416A JP6269888B1 JP 6269888 B1 JP6269888 B1 JP 6269888B1 JP 2017132416 A JP2017132416 A JP 2017132416A JP 2017132416 A JP2017132416 A JP 2017132416A JP 6269888 B1 JP6269888 B1 JP 6269888B1
Authority
JP
Japan
Prior art keywords
cancer
cyclopropane
carbonyl
amino
dihydrospiro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017132416A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018021013A (ja
Inventor
正樹 浅田
正樹 浅田
耕輔 谷
耕輔 谷
雅也 廣部
雅也 廣部
悟法 樋口
悟法 樋口
和寛 渕辺
和寛 渕辺
玲 及川
玲 及川
透 小谷
透 小谷
裕嗣 高野
裕嗣 高野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Priority to JP2017237151A priority Critical patent/JP6922712B2/ja
Application granted granted Critical
Publication of JP6269888B1 publication Critical patent/JP6269888B1/ja
Publication of JP2018021013A publication Critical patent/JP2018021013A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2017132416A 2016-07-07 2017-07-06 医薬用途 Active JP6269888B1 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2017237151A JP6922712B2 (ja) 2016-07-07 2017-12-11 医薬用途

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016134847 2016-07-07
JP2016134847 2016-07-07

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017237151A Division JP6922712B2 (ja) 2016-07-07 2017-12-11 医薬用途

Publications (2)

Publication Number Publication Date
JP6269888B1 true JP6269888B1 (ja) 2018-01-31
JP2018021013A JP2018021013A (ja) 2018-02-08

Family

ID=61074787

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017132416A Active JP6269888B1 (ja) 2016-07-07 2017-07-06 医薬用途
JP2017237151A Expired - Fee Related JP6922712B2 (ja) 2016-07-07 2017-12-11 医薬用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017237151A Expired - Fee Related JP6922712B2 (ja) 2016-07-07 2017-12-11 医薬用途

Country Status (1)

Country Link
JP (2) JP6269888B1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113234012A (zh) * 2021-06-01 2021-08-10 青岛化赫医药科技有限公司 一种3-甲氨基吡啶及其衍生物或其盐的制备方法

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230390303A1 (en) * 2020-11-13 2023-12-07 Ono Pharmaceutical Co., Ltd. Cancer treatment by combination of ep4 antagonist and immune checkpoint inhibitor
CN114790186A (zh) * 2021-01-25 2022-07-26 武汉人福创新药物研发中心有限公司 作为ep4拮抗剂的稠环化合物及其制备方法和用途
WO2022247862A1 (zh) * 2021-05-28 2022-12-01 南京明德新药研发有限公司 苯并螺杂环衍生物及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU756333B2 (en) * 1998-03-13 2003-01-09 Merck Frosst Canada & Co. Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
US6211197B1 (en) * 1998-10-07 2001-04-03 Merck Frosst Canada & Co. Prostaglandin receptor ligands
AU2001278771A1 (en) * 2000-08-22 2002-03-04 Ono Pharmaceutical Co. Ltd. Carboxylic acid derivatives, process for producing the same and drugs containingthe same as the active ingredient
GB0031302D0 (en) * 2000-12-21 2001-01-31 Glaxo Group Ltd Napthalene derivatives
KR20040022238A (ko) * 2001-08-09 2004-03-11 오노 야꾸힝 고교 가부시키가이샤 카르복실산 유도체 화합물 및 그 화합물을 유효성분으로서 함유하는 약제
WO2016088903A1 (en) * 2014-12-05 2016-06-09 Takeda Pharmaceutical Company Limited Heterocyclic compounds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113234012A (zh) * 2021-06-01 2021-08-10 青岛化赫医药科技有限公司 一种3-甲氨基吡啶及其衍生物或其盐的制备方法

Also Published As

Publication number Publication date
JP2018087189A (ja) 2018-06-07
JP2018021013A (ja) 2018-02-08
JP6922712B2 (ja) 2021-08-18

Similar Documents

Publication Publication Date Title
US12497377B2 (en) Tricyclic spiro compound
JP6323629B1 (ja) Ｅｐ４拮抗薬と免疫チェックポイント阻害薬を含んでなる組み合わせ
JP6269888B1 (ja) 医薬用途
CA2973330C (en) Tricyclic spiro compound
HK1239657B (zh) 三环螺环化合物
HK40025525A (en) Tricyclic spiro compound
HK1239657A1 (en) Tricyclic spiro compound

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20171110

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20171110

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20171110

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20171121

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20171205

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20171218

R150 Certificate of patent or registration of utility model

Ref document number: 6269888

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250